Effects of forced uncoupling protein 1 expression in 3T3-L1 cells on mitochondrial function and lipid metabolism

Journal of Lipid Research

Volumn 48, Issue 4, 2007, Pages 826-836

  Si, Yaguang ^a   Palani, Santhosh ^c   Jayaraman, Arul ^c   Lee, Kyongbum ^b  

^a TUFTS UNIVERSITY   (United States)

^b Tufts University   (United States)

^c Texas AandM University   (United States)

Author keywords

Adipocyte metabolic profile; Cellular ATP content; Glucose starvation

Indexed keywords

BIOLOGICAL MARKER; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LEPTIN; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ENERGY; CONTROLLED STUDY; DOWN REGULATION; ELECTROPORATION; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE; GENE EXPRESSION; GLUCOSE TRANSPORT; LIPID METABOLISM; LIPOGENESIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UCP1 GENE; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DOWN-REGULATION; FATTY ACIDS; GLYCERIDES; ION CHANNELS; LIPID METABOLISM; LIPIDS; MICE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS;

EID: 34147147434     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600343-JLR200     Document Type: Article

References (56)

1. Wickelgren, I. 1998. Obesity: how big a problem? Science. 280: 1364-1367.
2. Scheen, A. J. 2000. From obesity to diabetes: why, when and who? Acta Clin. Belg. 55: 9-15.
3. Saltiel, A. R. 2001. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell. 104: 517-529.
4. Colditz, G. A., W. C. Willett, M. J. Stampfer, J. E. Manson, C. H. Hennekens, R. A. Arky, and F. E. Speizer. 1990. Weight as a risk factor for clinical diabetes in women. Am. J. Epidemiol. 132: 501-513.
5. Kissebah, A. H., and G. R. Krakower. 1994. Regional adiposity and morbidity. Physiol. Rev. 74: 761-811.
6. Steppan, C. M., S. T. Bailey, S. Bhat, E. J. Brown, R. R. Banerjee, C. M. Wright, H. R. Patel, R. S. Ahima, and M. A. Lazar. 2001. The hormone resistin links obesity to diabetes. Nature. 409: 307-312.
7. Yamauchi, T., J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-946.
8. Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259: 87-91.
9. Pickup, J. C., M. B. Mattock, G. D. Chusney, and D. Burt. 1997. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 40: 1286-1292.
10. Boden, G. 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 46: 3-10.
11. Charles, M. A., E. Eschwege, N. Thibult, J. R. Claude, J. M. Warnet, G. E. Rosselin, J. Girard, and B. Balkau. 1997. The role of nonesterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia. 40: 1101-1106.
12. Paolisso, G., P. A. Tataranni, J. E. Foley, C. Bogardus, B. V. Howard, and E. Ravussin. 1995. A high concentration of fasting plasma nonesterified fatty acids is a risk factor for the development of NIDDM. Diabetologia. 38: 1213-1217.
13. Yin, W., D. Liao, Z. Wang, S. Xi, K. Tsutsumi, T. Koike, J. Fan, G. Yi, Q. Zhang, Z. Yuan, et al. 2004. NO-1886 inhibits size of adipocytes, suppresses plasma levels of tumor necrosis factor-[alpha] and free fatty acids, improves glucose metabolism in high-fat/high-sucrosefed miniature pigs. Pharmacol. Res. 49: 199-206.
14. Bergman, R. N., and S. D. Mittelman. 1998. Central role of the adipocyte in insulin resistance. J. Basic Clin. Physiol. Pharmacol. 9: 205-221.
15. Nicholls, D. G., and R. M. Locke. 1984. Thermogenic mechanisms in brown fat. Physiol. Rev. 64: 1-64.
16. Kopecky, J., G. Clarke, S. Enerback, B. Spiegelman, and L. P. Kozak. 1995. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J. Clin. Invest. 96: 2914-2923.
17. Orci, L., W. S. Cook, M. Ravazzola, M. Y. Wang, B. H. Park, R. Montesano, and R. H. Unger. 2004. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc. Natl. Acad. Sci. USA. 101: 2058-2063.
18. Tiraby, C., G. Tavernier, C. Lefort, D. Larrouy, F. Bouillaud, D. Ricquier, and D. Langin. 2003. Acquirement of brown fat cell features by human white adipocytes. J. Biol. Chem. 278: 33370-33376.
19. Christian, M., E. Kiskinis, D. Debevec, G. Leonardsson, R. White, and M. G. Parker. 2005. RIP140-targeted repression of gene expression in adipocytes. Mol. Cell. Biol. 25: 9383-9391.
20. Hauner, H., T. Skurk, and M. Wabitsch. 2001. Cultures of human adipose precursor cells. In Adipose Tissue Protocols. G. Ailhaud, editor. Humana Press, Totowa, NJ. xiii.
21. Schmittgen, T. D., and B. A. Zakrajsek. 2000. Effect of experimental treatment on housekeeping gene expression: validation by realtime, quantitative RT-PCR. J. Biochem. Biophys. Methods. 46: 69-81.
22. Sottile, V., and K. Seuwen. 2001. A high-capacity screen for adipogenic differentiation. Anal. Biochem. 293: 124-128.
23. Trinder, P. 1969. Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22: 158-161.
24. Loomis, M. E. 1961. An enzymatic fluorometric method for the determination of lactic acid in serum. J. Lab. Clin. Med. 57: 966-969.
25. Guarino, R. D., L. E. Dike, T. A. Haq, J. A. Rowley, J. B. Pitner, and M. R. Timmins. 2004. Method for determining oxygen consumption rates of static cultures from microplate measurements of pericellular dissolved oxygen concentration. Biotechnol. Bioeng. 86: 775-787.
26. Yu, Y. H., and H. Zhu. 2004. Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes. Am. J. Physiol. Endocrinol. Metab. 286: E402-E410.
27. 2-capture assay for evaluation of substrate oxidation rates of cells in culture. Biotechniques. 24: 803-808.
28. Patsouris, D., S. Mandard, P. J. Voshol, P. Escher, N. S. Tan, L. M. Havekes, W. Koenig, W. Marz, S. Tafuri, W. Wahli, et al. 2004. PPAR{alpha} governs glycerol metabolism. J. Clin. Invest. 114: 94-103.
29. Ricquier, D., and F. Bouillaud. 2000. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem. J. 345: 161-179.
30. Rentsch, J., and M. Chiesi. 1996. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett. 379: 55-59.
31. Green, H., and O. Kehinde. 1975. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 5: 19-27.
32. Lin, Y., A. H. Berg, P. Iyengar, T. K. Lam, A. Giacca, T. P. Combs, M. W. Rajala, X. Du, B. Rollman, W. Li, et al. 2005. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 280: 4617-4626.
33. Rognstad, R., and J. Katz. 1969. The effect of 2,4-dinitrophenol on adipose-tissue metabolism. Biochem. J. 111: 431-444.
34. Rossmeisl, M., I. Syrovy, F. Baumruk, P. Flachs, P. Janovska, and J. Kopecky. 2000. Decreased fatty acid synthesis due to mitochondrial uncoupling in adipose tissue. FASEB J. 14: 1793-1800.
35. Cabrero, A., G. Llaverias, N. Roglans, M. Alegret, R. Sanchez, T. Adzet, J. C. Laguna, and M. Vazquez. 1999. Uncoupling protein-3 mRNA levels are increased in white adipose tissue and skeletal muscle of bezafibrate-treated rats. Biochem. Biophys. Res. Commun. 260: 547-556.
36. Emilsson, V., J. O'Dowd, S. Wang, Y. L. Liu, M. Sennitt, R. Heyman, and M. A. Cawthorne. 2000. The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat. Metabolism. 49: 1610-1615.
37. Fukui, Y., S. Masui, S. Osada, K. Umesono, and K. Motojima. 2000. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes. 49: 759-767.
38. Matsuda, J., K. Hosoda, H. Itoh, C. Son, K. Doi, I. Hanaoka, G. Inoue, H. Nishimura, Y. Yoshimasa, Y. Yamori, et al. 1998. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes. Diabetes. 47: 1809-1814.
39. Wilson-Fritch, L., S. Nicoloro, M. Chouinard, M. A. Lazar, P. C. Chui, J. Leszyk, J. Straubhaar, M. P. Czech, and S. Corvera. 2004. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114: 1281-1289.
40. Flachs, P., J. Novotny, F. Baumruk, K. Bardova, L. Bourova, I. Miksik, J. Sponarova, P. Svoboda, and J. Kopecky. 2002. Impaired noradrenaline-induced lipolysis in white fat of aP2-Ucp1 transgenic mice is associated with changes in G-protein levels. Biochem. J. 364: 369-376.
41. Kopecky, J., M. Rossmeisl, Z. Hodny, I. Syrovy, M. Horakova, and P. Kolarova. 1996. Reduction of dietary obesity in aP2-Ucp transgenic mice: mechanism and adipose tissue morphology. Am. J. Physiol. 270: E776-E786.
42. Li, B., J. O. Holloszy, and C. F. Semenkovich. 1999. Respiratory uncoupling induces delta-aminolevulinate synthase expression through a nuclear respiratory factor-1-dependent mechanism in HeLa cells. J. Biol. Chem. 274: 17534-17540.
43. Bashan, N., E. Burdett, A. Guma, R. Sargeant, L. Tumiati, Z. Liu, and A. Klip. 1993. Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am. J. Physiol. 264: C430-C440.
44. Mercado, C. L., J. N. Loeb, and F. Ismail-Beigi. 1989. Enhanced glucose transport in response to inhibition of respiration in Clone 9 cells. Am. J. Physiol. 257: C19-C28.
45. Kang, J., E. Heart, and C. K. Sung. 2001. Effects of cellular ATP depletion on glucose transport and insulin signaling in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 280: E428-E435.
46. Zhang, J. Z., A. Behrooz, and F. Ismail-Beigi. 1999. Regulation of glucose transport by hypoxia. Am. J. Kidney Dis. 34: 189-202.
47. 2+ efflux. FEBS Lett. 329: 67-71.
48. Jennings, R. B., K. A. Reimer, and C. Steenbergen. 1991. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J. Mol. Cell. Cardiol. 23: 1383-1395.
49. St-Pierre, J., M. D. Brand, and R. G. Boutilier. 2000. Mitochondria as ATP consumers: cellular treason in anoxia. Proc. Natl. Acad. Sci. USA. 97: 8670-8674.
50. Vinogradov, A. D. 2000. Steady-state and pre-steady-state kinetics of the mitochondrial F(1)F(o) ATPase: is ATP synthase a reversible molecular machine? J. Exp. Biol. 203: 41-49.
51. Wang, T., Y. Zang, W. Ling, B. E. Corkey, and W. Guo. 2003. Metabolic partitioning of endogenous fatty acid in adipocytes. Obes. Res. 11: 880-887.
52. Pfeiffer, T., S. Schuster, and S. Bonhoeffer. 2001. Cooperation and competition in the evolution of ATP-producing pathways. Science. 292: 504-507.
53. Gajewski, C. D., L. Yang, E. A. Schon, and G. Manfredi. 2003. New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters. Mol. Biol. Cell. 14: 3628-3635.
54. Nieminen, A. L., A. K. Saylor, B. Herman, and J. J. Lemasters. 1994. ATP depletion rather than mitochondrial depolarization mediates hepatocyte killing after metabolic inhibition. Am. J. Physiol. 267: C67-C74.
55. Snyder, J. W., J. G. Pastorino, A. P. Thomas, J. B. Hoek, and J. L. Farber. 1993. ATP synthase activity is required for fructose to protect cultured hepatocytes from the toxicity of cyanide. Am. J. Physiol. 264: C709-C714.
56. Buttgereit, F., and M. D. Brand. 1995. A hierarchy of ATP-consuming processes in mammalian cells. Biochem. J. 312: 163-167.